Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Torrent Pharmaceuticals Ltd ( (IN:TORNTPHARM) ) has shared an update.
Torrent Pharmaceuticals Ltd has disclosed that the Joint Commissioner of the Central GST, Ahmedabad South Commissionerate, has imposed a penalty of ₹41.33 crore under Section 74 of the Central Goods and Service Tax Act, 2017, due to an alleged erroneous refund on the export of goods. The company plans to appeal the order and does not anticipate any significant financial impact from this penalty, expecting a favorable outcome.
More about Torrent Pharmaceuticals Ltd
Torrent Pharmaceuticals Ltd is a prominent player in the pharmaceutical industry, focusing on the development and manufacturing of generic medicines. The company is headquartered in Ahmedabad, India, and is known for its wide range of pharmaceutical products catering to various therapeutic segments.
Average Trading Volume: 9,629
Technical Sentiment Signal: Buy
Current Market Cap: 1270.4B INR
Learn more about TORNTPHARM stock on TipRanks’ Stock Analysis page.